FDA Adverse Event Monitoring System (AEMS) Electronic Submissions: Streamlining Regulatory Safety Reporting
The FDA Adverse Event Monitoring System (AEMS) Electronic Submissions framework marks a transformative step in modernizing regulatory safety reporting. Replacing the former FDA Adverse Event Reporting System (FAERS), AEMS introduces a unified, centralized platform designed to improve the quality, consistency, and efficiency of adverse event data submissions.
NextGen eCTD Software Supported by WHO: Advancing Global Regulatory Submissions with Masuu Global
The world pharmaceutical sector is changing fast and NextGen eCTD Software supported by WHO is emerging as a main force behind harmonized, efficient regulatory submissions.
NextGen eCTD Software Supported Country Kuwait: Preparing for MOH Compliance and 2025 eCTD Mandate
Kuwait is gradually improving its pharmaceutical regulatory system and NextGen eCTD software supported country Kuwait is one of the critical factors that companies should take into account when entering the country successfully.
What Is Good Laboratory Practice (GLP)?
In the pharmaceutical industry, ensuring the safety, quality, and reliability of laboratory data is critical before any drug reaches the market. Good Laboratory Practice (GLP) is a globally recognized quality system that governs how non-clinical laboratory studies are planned, performed, monitored, recorded, and reported.
What is the Global Substance Registration System (GSRS)?
In the modern pharmaceutical landscape, where global harmonization and data accuracy are critical, the Global Substance Registration System (GSRS) has emerged as a powerful solution for substance identification and standardization.